InDex Pharmaceuticals Holding AB (OSTO:INDEX) Market Cap : kr3,686.5 Mil (As of Jun. 20, 2024)

View and export this data going back to 2016. Start your Free Trial

What is InDex Pharmaceuticals Holding AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). InDex Pharmaceuticals Holding AB's share price for the quarter that ended in Mar. 2024 was kr0.292. InDex Pharmaceuticals Holding AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 532.7 Mil. Therefore, InDex Pharmaceuticals Holding AB's market cap for the quarter that ended in Mar. 2024 was kr155.5 Mil.

InDex Pharmaceuticals Holding AB's quarterly market cap declined from Sep. 2023 (kr426.2 Mil) to Dec. 2023 (kr136.4 Mil) but then increased from Dec. 2023 (kr136.4 Mil) to Mar. 2024 (kr155.5 Mil).

InDex Pharmaceuticals Holding AB's annual market cap declined from Dec. 2021 (kr926.9 Mil) to Dec. 2022 (kr450.1 Mil) and declined from Dec. 2022 (kr450.1 Mil) to Dec. 2023 (kr136.4 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. InDex Pharmaceuticals Holding AB's Enterprise Value for Today is kr3,418.7 Mil.

InDex Pharmaceuticals Holding AB Market Cap Historical Data

The historical data trend for InDex Pharmaceuticals Holding AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InDex Pharmaceuticals Holding AB Market Cap Chart

InDex Pharmaceuticals Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

516.71

410.17

926.88

450.12

136.37

InDex Pharmaceuticals Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															202.16	282.32	426.15	136.37	155.54

Competitive Comparison of InDex Pharmaceuticals Holding AB's Market Cap

For the Biotechnology subindustry, InDex Pharmaceuticals Holding AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InDex Pharmaceuticals Holding AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InDex Pharmaceuticals Holding AB's Market Cap distribution charts can be found below:

* The bar in red indicates where InDex Pharmaceuticals Holding AB's Market Cap falls into.

InDex Pharmaceuticals Holding AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

InDex Pharmaceuticals Holding AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	kr0.256	*	532.688
	=	kr136.4

InDex Pharmaceuticals Holding AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	kr0.292	*	532.688
	=	kr155.5

InDex Pharmaceuticals Holding AB (OSTO:INDEX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

InDex Pharmaceuticals Holding AB Market Cap Related Terms

Thank you for viewing the detailed overview of InDex Pharmaceuticals Holding AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

InDex Pharmaceuticals Holding AB (OSTO:INDEX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InDex Pharmaceuticals Holding AB (OSTO:INDEX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Berzelius vag 13, Solna, SWE, 171 65

Website

https://www.indexpharma.com

InDex Pharmaceuticals Holding AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The company's main asset is the drug candidate cobitolimod, which is being evaluated in the phase III study as a treatment for moderate to severe ulcerative colitis - a disabling, chronic inflammation of the colon. It has also developed a platform of patent-protected substances, so-called DNA-based Immunomodulatory Sequences, with the potential to be used in the treatment of various immunological diseases.

InDex Pharmaceuticals Holding AB (OSTO:INDEX) Headlines

No Headlines